WHO Moves Into Prequalification Of Biosimilars; Two Anticancers First In Line

 
• By Vibha Sharma
HER2
WHO Aims to prequalify two anti-cancer biosimilars, including trastuzumab for breast cancer • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics